Home/Filings/4/0001144204-18-032120
4//SEC Filing

Fodor William 4

Accession 0001144204-18-032120

CIK 0001563665other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 8:22 PM ET

Size

7.8 KB

Accession

0001144204-18-032120

Insider Transaction Report

Form 4
Period: 2018-05-29
Fodor William
Chief Scientific Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-05-29+104,643104,643 total
    Exercise: $2.72Exp: 2028-05-29Common Stock, par value $0.01 per share (104,643 underlying)
  • Award

    Stock Option (right to buy)

    2018-05-29+104,643104,643 total
    Exercise: $2.72Exp: 2028-05-29Common Stock, par value $0.01 per share (104,643 underlying)
Footnotes (2)
  • [F1]Incentive Stock Option shares that vest in four equal installments on December 31, 2018, 2019, 2020 and 2021.
  • [F2]Non-Qualified Stock Option that shares vest based on certain performance milestones.

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeother

Related Parties

1
  • filerCIK 0001735547

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 8:22 PM ET
Size
7.8 KB